<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02119494</url>
  </required_header>
  <id_info>
    <org_study_id>205.529</org_study_id>
    <nct_id>NCT02119494</nct_id>
  </id_info>
  <brief_title>Phenotypes of COPD in Central and Eastern Europe</brief_title>
  <acronym>POPE</acronym>
  <official_title>POPE-Study: Phenotypes Of COPD in Central and Eastern Europe Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zuzana Zbožínková, M.Sc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Masaryk University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the representation of COPD patients in terms of
      categories and phenotypes of the disease in selected countries in Central and Eastern Europe
      (CEE). The results of The POPE study will allow for evaluation of the differences in clinical
      approaches and treatment practices. The following countries are represented in The POPE
      study: Czech Republic, Slovakia, Austria, Poland, Hungary, Russia, Croatia, Serbia, Slovenia,
      Estonia, Latvia and Bulgaria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic Obstructive Pulmonary Disease (COPD) is a significant cause of morbidity and
      mortality in Europe and a major consumer of resources in both primary and secondary
      healthcare (1,2). Both clinical features of disease severity and quality of COPD patient care
      may have substantial influence on disease outcomes. Traditionally, COPD has been categorized
      using the FEV1 (forced expiratory volume at one second ) - based GOLD (The Global Initiative
      for Chronic Obstructive Lung Disease) classification . Other factors independently associated
      with survival include age, dyspnoea, health status, hyperinflation, gas exchange
      abnormalities, exacerbation frequency, exercise capacity, pulmonary hemodynamic, and
      nutritional status (3). Together these factors explain some of the existent heterogeneity
      within each GOLD stage in terms of symptoms, exacerbations, quality of life and exercise
      capacity (4).

      Recently, interest has emerged for the identification of clinical COPD phenotypes, as defined
      by ''a single or combination of disease attributes that describe difference between
      individuals with COPD as they relate to clinically meaningful outcomes'' (5). Many previous
      studies have attempted to identify and quantify the prevalence of different phenotypes of
      COPD using populations of various sources, severities, and particularities. Yet there is no
      consensus on the number and definition of different phenotypes. However, there must be a
      compromise between the oversimplification of the term COPD as a definition that encompasses
      the entire spectrum of patients with incompletely reversible airflow obstruction caused
      largely by smoking and the complexity of considering each patient individually as an orphan
      disease.

      The most frequently reported phenotypes are emphysema and chronic bronchitis, along with a
      subset of asthma sufferers. Recently, an extended list of proposed phenotypes have been
      proposed (6) including: (A) infrequent exacerbators with either chronic bronchitis or
      emphysema; (B) overlap COPD-asthma; (C) frequent exacerbators with emphysema predominant; and
      (D) frequent exacerbators with chronic bronchitis predominant. While there is consensus of
      substantial, but not complete, overlap among these phenotypes, the distribution of these
      phenotypes may differ widely between different countries and healthcare systems.

      Thus, the objectives of this study are to better understand the patient characteristics and
      treatment patterns of those diagnosed with COPD between different CEE countries. Knowledge of
      this information may provide insight into the variability of phenotypes between different
      healthcare systems and may subsequently contribute to a better understanding of the factors
      associated with patient outcomes and have the potential to improve the care of COPD patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>7 Months</target_duration>
  <primary_outcome>
    <measure>The distribution of COPD patients according to GOLD 2011 grades</measure>
    <time_frame>7 months</time_frame>
    <description>The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 classifies patients according to airflow limitation into four grades: GOLD1, Mild; GOLD 2, Moderate; GOLD 3, Severe; GOLD 4, Very severe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The distribution of COPD patients according to GOLD 2011 categories of risk (A. B, C, D)</measure>
    <time_frame>7 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The prevalence of various COPD phenotypes</measure>
    <time_frame>7 months</time_frame>
    <description>The COPD phenotypes are: bronchitis, emphysema phenotype, frequent exacerbators, pulmonary cachexia, COPD and asthma overlap, and COPD and bronchiectasis overlap</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The prevalence various medication prescription</measure>
    <time_frame>7 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The prevalence of long term oxygen therapy use</measure>
    <time_frame>7 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The prevalence of surgical treatments in COPD patients</measure>
    <time_frame>7 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The use of body plethysmography, bronchodilator test, carbon monoxide diffusing capacity testing, bronchial challenge test and FeNO test in ambulatory care</measure>
    <time_frame>7 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">3504</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with COPD who visit selected specialised pulmonology clinics in the given time
        period.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 40 years

          2. Clinical diagnosis of COPD with post-bronchodilator FEV1/FVC &lt; 0.7

          3. Smoking burden ≥ 10 pack-years in smokers (group A). Evidence of exposure to at least
             one other typical inhaled COPD risk factor: environmental tobacco smoke, professional
             exposures, etc. (group B) Each country will include 300 COPD subjects with positive
             history of smoking (at least 10 pack-years). Consecutive non-smokers with COPD can be
             enrolled above this limit. Institute for Biostatistics and Analyses, Masaryk
             University, Brno, The Czech Republic will analyze both COPD groups (A and B)
             separately

          4. Stable disease for at least 4 weeks

          5. Outpatient status

          6. Informed Consent

        Exclusion Criteria:

          1. Exacerbation of COPD and/or instable co-morbid condition

          2. Patient during hospital stay for whatever reason (lung or co-morbidities)

          3. Patient is not able and willing to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arschang Valipour, Assoc. Prof., MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Wiener Krankenanstaltenverbund</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vladimir Koblizek, MD, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Hradec Kralove</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ruzena Tkacova, Prof., MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Pavol Jozef Šafárik University in Košice</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neven Tudoric, Prof., MD, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>University of Zagreb, Clinical Hospital Dubrava</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kyrill Zykov, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Moscow State University of Medicine and Dentistry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Attila Somfay, Prof., MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Szeged, Faculty of Medicine, Dept. of Pulmonology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adam Barczyk, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Katedra i Klinika Pneumonologii, Śląski Uniwersytet Medyczny</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Miravitlles, Prof., MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitari Vall d'hebron Barcelona, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Internal Medicine, University Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>A-6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AKH Linz, Department of Pulmonary Medicine</name>
      <address>
        <city>Linz</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SKA der PV Weyer/Enns</name>
      <address>
        <city>Mühlein</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulmonary Rehabilitation Centre, Therme Wien</name>
      <address>
        <city>Vienna</city>
        <zip>1100</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ludwig Boltzmann Institute</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic for pneumonology and phisiatry, UMHAT &quot;Dr. Georgi Stranski&quot;</name>
      <address>
        <city>Pleven</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Respiratory Diseases, Medical University</name>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulmonary Diseases Clinic, Military Medical Academy</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Pulmonology, MHAT &quot;st. Marina&quot;</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital</name>
      <address>
        <city>Osijek</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Centre</name>
      <address>
        <city>Rijeka</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Centre</name>
      <address>
        <city>Split</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Centre</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Dubrava</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulmonary Outpatient Clinic, University Hospital Hradec Králové</name>
      <address>
        <city>Hradec Králové</city>
        <zip>500 05</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Plicní ambulance Karlovy Vary</name>
      <address>
        <city>Karlovy Vary</city>
        <zip>36066</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Plicní ambulance Ostrava Poruba</name>
      <address>
        <city>Ostrava</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Plicní ambulance Teplice</name>
      <address>
        <city>Teplice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baja St. Rókus Hospital Patient Lung Care Institute</name>
      <address>
        <city>Baja</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IZO PULM Health Service Ltd.</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Újpest Non-Profit Health Care Services Ltd.</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Csongrád County Hospital for Chest Diseases</name>
      <address>
        <city>Deszk</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elizabeth House Care Ltd.</name>
      <address>
        <city>Gödöllő</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth Hospital Pulmonary Care Institute</name>
      <address>
        <city>Jászberény</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szabolcs-Szatmár-Bereg County Hospitals and University Teaching Hospital</name>
      <address>
        <city>Nyíregyháza</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federated Institutes of Health Institute of Pulmonary Care</name>
      <address>
        <city>Pécs</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szarvas Respiratory Ltd.</name>
      <address>
        <city>Szarvas</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Institution of Dr. Laszlo Romics Pulmonary Care</name>
      <address>
        <city>Érd</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Centre Balvi</name>
      <address>
        <city>Balvi</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bauska Hospital</name>
      <address>
        <city>Bauska</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Hospital of Jekabpils</name>
      <address>
        <city>Jekabpils</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulatory Clinic Jelgava</name>
      <address>
        <city>Jelgava</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulatory Clinic Dubulti</name>
      <address>
        <city>Jurmala</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuldīga Hospital</name>
      <address>
        <city>Kuldīga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Hospital of Liepaja</name>
      <address>
        <city>Liepaja</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Madona Hospital</name>
      <address>
        <city>Madona</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Privat practice Viktorija Vevere</name>
      <address>
        <city>Rezekne</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Centre 4, Ltd</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LU MPI Institute privat practice</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pauls Stradins Clinical University Hospital</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riga 1st Hospital</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riga East Clinical University Hospital, In-patient Department &quot;Centre of Tuberculosis and Lung Diseases</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniClinic</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Centre</name>
      <address>
        <city>Talsi</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>rivat practice Ilona Uzbeka</name>
      <address>
        <city>Valka</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Privat practice Dace Harasimjuka</name>
      <address>
        <city>Valmiera</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sia &quot;Bini&quot;</name>
      <address>
        <city>Ventspils</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddział Chorób Płuc i Niewydolności Oddychania, Kujawsko - Pomorskie; Centrum Pulmonologii w Bydgoszczy</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-326</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Alergologii i Pneumonologii, Uniwersyteckie Centrum Kliniczne, Szpital Gdańskiego Uniwersytetu Medycznego,</name>
      <address>
        <city>Gdansk</city>
        <zip>80-211</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddział Chorób Płuc, Wojewódzkie Centrum Szpitalne Kotliny Jeleniogórskiej,</name>
      <address>
        <city>Jelenia Góra</city>
        <zip>58-506</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katedra i Klinika Pneumonologii, Śląski Uniwersytet Medyczny</name>
      <address>
        <city>Katowice</city>
        <zip>40-752</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki, Oddział Kliniczny Kliniki Pulmonologii</name>
      <address>
        <city>Krakow</city>
        <zip>31-066</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katedra i Klinika Pulmonologii, Alergologii i Onkologii Pulmonologicznej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu</name>
      <address>
        <city>Poznan</city>
        <zip>60-569</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katedra i Klinika Chorób Wewnętrznych, Pneumonologii i Alergologii, Samodzielny Publiczny Centralny Szpital Kliniczny Warszawski Uniwersytet Medyczny,</name>
      <address>
        <city>Warsaw</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Budget Educational Institution of High Professional Education &quot;Kazan State Medical University&quot;</name>
      <address>
        <city>Kazan</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>I.M.Sechenov First Moscow State Medical University, University Hospital #1, Outpatient Department</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moscow State City Clinical Hospital No. 24</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moscow State University of Medicine and Dentistry named after A.I.Evdokimov</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulmonology Research Institute</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GBOU VPO Samara State Medical University</name>
      <address>
        <city>Samara</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Pulmonology of Scientific and Clinical Center of Interstitial and Orphan Lung Diseases</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ufa State City Clinical Hospital</name>
      <address>
        <city>Ufa</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vladivostok Clinical Hospital No.1</name>
      <address>
        <city>Vladivostok</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic for Pulmonary Diseases, Clinical Centre of Serbia</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Institute for Lung Diseases and Tuberculosis</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic for Pulmonary Diseases, Clinical Centre Kragujevac</name>
      <address>
        <city>Kragujevac</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic for Pulmonary Diseases, Clinical Center of Nis</name>
      <address>
        <city>Nis</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Pulmonary Diseases and TB, Clinical Centre Vojvodina</name>
      <address>
        <city>Novi Sad</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FNsP F.D. Roosevelta</name>
      <address>
        <city>Banská Bystrica</city>
        <zip>97517</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NsP Sv. Jakuba</name>
      <address>
        <city>Bardejov</city>
        <zip>085 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika pneumológie a ftizeológie LF SZU a UNB,</name>
      <address>
        <city>Bratislava</city>
        <zip>821 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zdravotné stredisko Fedinova</name>
      <address>
        <city>Bratislava</city>
        <zip>85101</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulancia pneumológie a ftizeológie, ZAPA JJ s.r.o.,</name>
      <address>
        <city>Levice</city>
        <zip>934 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika tubekulózy a respiračných chorôb JLF UK a UNM</name>
      <address>
        <city>Martin</city>
        <zip>036 59</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dionea, s.r.o.</name>
      <address>
        <city>Nové Zámky</city>
        <zip>94001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pľúcna ambulancia</name>
      <address>
        <city>Poprad</city>
        <zip>05801</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NsP</name>
      <address>
        <city>Považská Bystrica</city>
        <zip>017 26</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zdravotné stredisko Rimava</name>
      <address>
        <city>Rimavská Sobota</city>
        <zip>979 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alveola, d.o.o.</name>
      <address>
        <city>Maribor</city>
        <zip>3326</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zdravstveni dom Murska Sobota</name>
      <address>
        <city>Murska Sobota</city>
        <zip>9000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bolnišnica Topolšica</name>
      <address>
        <city>Topolšica</city>
        <zip>3326</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Bulgaria</country>
    <country>Croatia</country>
    <country>Czech Republic</country>
    <country>Hungary</country>
    <country>Latvia</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Slovakia</country>
    <country>Slovenia</country>
  </location_countries>
  <reference>
    <citation>Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med. 2010 Mar 22;170(6):560-5. doi: 10.1001/archinternmed.2010.17. Erratum in: Arch Intern Med. 2010 Jun 28;170(12):1023.</citation>
    <PMID>20308643</PMID>
  </reference>
  <reference>
    <citation>Menn P, Heinrich J, Huber RM, Jörres RA, John J, Karrasch S, Peters A, Schulz H, Holle R; KORA Study Group. Direct medical costs of COPD--an excess cost approach based on two population-based studies. Respir Med. 2012 Apr;106(4):540-8. doi: 10.1016/j.rmed.2011.10.013. Epub 2011 Nov 18.</citation>
    <PMID>22100535</PMID>
  </reference>
  <reference>
    <citation>Dolan S, Varkey B. Prognostic factors in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2005 Mar;11(2):149-52. Review.</citation>
    <PMID>15699788</PMID>
  </reference>
  <reference>
    <citation>Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010 Sep 10;11:122. doi: 10.1186/1465-9921-11-122.</citation>
    <PMID>20831787</PMID>
  </reference>
  <reference>
    <citation>Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010 Sep 1;182(5):598-604. doi: 10.1164/rccm.200912-1843CC. Epub 2010 Jun 3.</citation>
    <PMID>20522794</PMID>
  </reference>
  <reference>
    <citation>Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Trigueros JA, Piñera P, Simón A, Riesco JA, Ancochea J, Soriano JB. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir J. 2013 Mar;22(1):117-21. doi: 10.4104/pcrj.2013.00016.</citation>
    <PMID>23443227</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2014</study_first_submitted>
  <study_first_submitted_qc>April 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2014</study_first_posted>
  <last_update_submitted>April 2, 2016</last_update_submitted>
  <last_update_submitted_qc>April 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Masaryk University</investigator_affiliation>
    <investigator_full_name>Zuzana Zbožínková, M.Sc.</investigator_full_name>
    <investigator_title>project manager</investigator_title>
  </responsible_party>
  <keyword>chronic obstructive pulmonary disease</keyword>
  <keyword>phenotypes</keyword>
  <keyword>categories</keyword>
  <keyword>stage</keyword>
  <keyword>GOLD</keyword>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

